A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen ...

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced today that new data supporting its ...

Century Therapeutics, Inc. (NASDAQ: IPSC) has announced two critical presentations at the 28th Annual Meeting of the American ...

Key trends and challenges are shaping the next era of advanced therapies, from FDA momentum to broader patient access.

Fran Gregory, PharmD, MBA, VP of emerging therapies at Cardinal Health, talks about the importance of market access strategies in the cell and gene therapy space.

Emma Dimery joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

The American Association for Cancer Research’s annual conference continued Tuesday with Marengo Therapeutics making progress ...

L7 Informatics’ Marcia Blackmoore on how structured data, digital workflows, and real-time orchestration are helping CDMOs deliver at scale without compromising quality.

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

Suzuki, R. (2025) Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants. Health, ...

Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...

Engineers and biologists at Dartmouth College have found that, just like word order affects meaning in a sentence, the placement of genes within a plasmid—known as gene syntax—can influence ...